plexin-A2 Activators
Plexin-A2 activators represent a diverse array of chemical compounds that enhance the protein's functional activity through various signaling pathways, emphasizing its role in neuronal guidance and vascular development. Sema3A, as a natural ligand, directly activates Plexin-A2, initiating a cascade of cytoskeletal reorganization essential for neuronal pathfinding. Lysophosphatidic Acid and D-erythro-Sphingosine-1-phosphate modulate G-protein-coupled receptors and Rho GTPase activity, indirectly enhancing the Plexin-A2 pathway's influence on cellular dynamics and morphology. Forskolin's elevation of cAMP levels and subsequent PKA activation can phosphorylate substrates affecting Plexin-A2's role, while the modulation of RhoA by C3 Transferase and the inhibition of downstream ROCK by Y-27632, free base alter cellular motility and shape, core aspects of Plexin-A2 function. Similarly, NSC 23766, ML 141, and other GTPase modulators like Rac1 and Cdc42 inhibitors provide nuanced control over the cytoskeletal rearrangements and cellular processes guided by Plexin-A2.
The action of these activators is further nuanced by compounds affecting cytoskeletal elements and associated signaling proteins. (S)-(-)-Blebbistatin, by inhibiting myosin II, alters the contractility and motility directly relevant to Plexin-A2's mediation of cell movement. Jasplakinolide and Wiskostatin, through stabilization of actin filaments and inhibition of N-WASP, respectively, ensure that the actin dynamics necessary for Plexin-A2's influence on cellular architecture and migration are finely tuned. Each activator, whether affecting upstream signaling molecules or directly influencing the cytoskeletal components, orchestrates a symphony of cellular responses that enhance the specific functions of Plexin-A2, illustrating the complexity and precision of cellular signaling pathways and the potential for targeted modulation of this critical protein's activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Lysophosphatidic Acid engages in G-protein-coupled receptor signaling, influencing RhoA GTPase activity. RhoA is a known modulator of Plexin-A2 signaling, thus LPA can indirectly enhance Plexin-A2 mediated axonal guidance. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
(S)-(-)-Blebbistatin inhibits myosin II, affecting cellular contractility and motility. Since Plexin-A2 signaling is involved in cell movement and axon guidance, altering myosin II activity can indirectly affect Plexin-A2's role in these processes. | ||||||
Farnesyl pyrophosphate ammonium salt | 13058-04-3 | sc-200847 sc-200847A | 1 mg 5 mg | $478.00 $1977.00 | ||
Farnesyl pyrophosphate serves as a substrate for protein farnesylation, a post-translational modification that affects many signaling proteins. This modification can influence Rho GTPases, subsequently affecting Plexin-A2 signaling. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
D-erythro-Sphingosine-1-phosphate interacts with its receptors to modulate Rho GTPase activity, indirectly influencing Plexin-A2 function, particularly in neuronal guidance and vascular development. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates cAMP levels, activating PKA. PKA can phosphorylate various substrates, potentially influencing the cytoskeletal changes and cellular dynamics associated with Plexin-A2 signaling in neurons. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632, free base is a ROCK inhibitor, acting downstream of RhoA. As RhoA is part of the Plexin-A2 signaling pathway, inhibiting ROCK can lead to altered Plexin-A2 mediated responses, particularly in cellular shape and motility. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML 141 is a Cdc42 inhibitor, another Rho GTPase that influences the Plexin-A2 pathway. By inhibiting Cdc42, it can modulate the cellular effects mediated by Plexin-A2, especially in terms of neuronal network formation and plasticity. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments, enhancing cytoskeletal reorganization. This stabilization can potentiate the cellular changes required in Plexin-A2 mediated axonal guidance and cellular migration. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Wiskostatin is a N-WASP inhibitor, affecting the actin cytoskeleton. As the actin cytoskeleton is vital for Plexin-A2 mediated changes in cell shape and motility, inhibiting N-WASP can indirectly influence Plexin-A2 signaling pathways. | ||||||